Search Within

Nancy L. Geller

Formats
  1. Journal Article (57)
  2. Meeting Abstract (6)
  3. Conference Paper (2)
Groups
  1. Department of Medicine (37)
  2. Solid Tumor Oncology Division (37)
  3. Genitourinary Oncology Service (30)
  4. Survivorship Research (29)
  5. Surgery (16)
  6. Urology (15)

More Groups

People
  1. George Bosl (28)
  2. Howard Scher (20)
  3. Harry Herr (15)
  4. Pramod Sogani (14)
  5. Michael Morse (13)
  6. Alan Yagoda (12)

More People

Years
  1. 1993 (2)
  2. 1992 (1)
  3. 1991 (9)
  4. 1990 (10)
  5. 1989 (6)
  6. 1988 (12)

More Years

Publications
  1. Cancer (13)
  2. Journal of Clinical Oncology (11)
  3. Proceedings of the American Association for Cancer Research Annual Meeting (5)
  4. Cancer Research (4)
  5. Cancer Treatment Reports (4)
  6. Journal of Urology (4)

More Publications

Publishers
  1. Wiley Blackwell (16)
  2. American Society of Clinical Oncology (11)
  3. American Association for Cancer Research (9)
  4. Elsevier Science, Inc. (6)
  5. National Cancer Institute (4)
  6. Oxford University Press (4)

More Publishers

Results (65)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Recurrence in bone (B) versus recurrence at other sites (non-B) following adjuvant cyclophosphamide, methotrexate and fluorouracil (CMF) chemotherapy (CT) for stage II and stage III breast cancer
    Meeting Abstract

    Cooper, K.; Scher, H. I.; Geller, N. L.; Chan, E. Y. W.; Reichman, B.; Hakes, T. B.
    Proceedings of the American Association for Cancer Research Annual Meeting (1987)

    Fulltext@MSK | Save
  • Planned interim analysis and its role in cancer clinical trials
    Journal Article

    Geller, N. L.
    Journal of Clinical Oncology (1987)

    Fulltext@MSK | Save
  • The analysis of multiple end points in clinical trials
    Journal Article

    Pocock, S. J.; Geller, N. L.; Tsiatis, A. A.
    Biometrics (1987)

    Fulltext@MSK | Save
  • Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors
    Journal Article

    Bosl, G. J.; Geller, N. L.; Vogelzang, N. J.; Carey, R.; Auman, J.; Whitmore, W. F.; Herr, H.; Morse, M.; Sogani, P.; Chan, E.
    Journal of Clinical Oncology (1987)

    Fulltext@MSK | Save
  • An analysis of poor risk assignment in patients with germ cell tumours
    Journal Article

    Bosl, G. J.; Bajorin, D.; Geller, N. L.
    International Journal of Andrology (1987)

    Fulltext@MSK | Save
  • Gallium nitrate in prostatic cancer: Evaluation of antitumor activity and effects on bone turnover
    Journal Article

    Scher, H. I.; Curley, T.; Geller, N.; Dershaw, D.; Chan, E.; Nisselbaum, J.; Alcock, N.; Hollander, P.; Yagoda, A.
    Cancer Treatment Reports (1987)

    Fulltext@MSK | Save
  • Systemic absorption of a leucovorin mouth wash: A pharmacologic study
    Journal Article

    Fiore, J. J.; Kemeny, N. E.; Mehta, B. M.; Geller, N.; Grossano, D.; Murphy, D.
    Cancer Investigation (1987)

    Fulltext@MSK | Save
  • Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma: A randomized trial
    Journal Article

    Kemeny, N.; Daly, J.; Reichman, B.; Geller, N.; Botet, J.; Oderman, P.
    Annals of Internal Medicine (1987)

    Fulltext@MSK | Save
  • Randomized study of intrahepatic (H) vs. systemic (S) infusion of fluorodeoxyuridine (FUDR) in patients with liver metastases from colorectal carcinoma (CRC)
    Meeting Abstract

    Kemeny, N.; Daly, J.; Oderman, P.; Geller, N.
    Cancer Investigation (1986)

    Fulltext@MSK | Save
  • Improved prognosis of patients (Pts) entering clinical trials of chemotherapy (CT) of germ cell tumors (GCT)
    Meeting Abstract

    Bosl, G. J.; Geller, N.; Trust, A.
    Proceedings of the American Association for Cancer Research Annual Meeting (1986)

    Fulltext@MSK | Save